Navigation Links
Higher-Dose Copper IUDs Provide Better Pregnancy Protection

Intrauterine devices that contain higher doses of copper are more effective in preventing pregnancy than IUDs with lower copper doses, according to a new systematic review// of studies.

In addition, increasing the copper content does not cause an increase in side effects prompting removal of the device, such as bleeding and pain, the review found.

“In general, the comparative analyses suggest higher effectiveness and similar side effect profile with high-copper IUDs compared to low-copper ones,” concluded the review authors.

The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic.

The IUD is the most widely used reversible method of contraception in the world. Most IUDs consist of a plastic frame wrapped with copper wire, although the shape of the frame and the amount of copper wire vary among models.

The reviewers analyzed 34 randomized controlled trials that compared the effectiveness and side effects of different copper IUDs. More than 50,000 women from around the world were enrolled in these studies, which lasted from one year to 12 years.

Nine IUDs were included in the analysis. Most devices had a T-shaped or horseshoe-shaped design. The surface area of copper varied from 200 to 380 square millimeters.

According to the reviewers, the most well-studied IUD in these trials, the T380A, was also the most effective in preventing pregnancy. The TCu380A is the only copper IUD approved for use in the United States.

The T380A, sold under the trade name ParaGard, is a T-shaped device that contains 380 square millimeters of copper, the highest dose of all IUDs included in this analysis. In dir
'"/>




Page: 1 2 3

Related medicine news :

1. Copper has antiflu properties
2. High-Fat, Copper-Rich Diets Associated with Increased Rates of Cognitive Decline
3. Copper Alloys Surfaces Touted As Pathogen Killers
4. Cancer Cells Forming Blood Vessels Send Their Copper to the Edge
5. Diet Rich in Copper- Good for Heart
6. Trial Run of Copper to Combat MRSA
7. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
8. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
9. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
10. Leeches Provide Clues Regarding The Prevention Of Heart Disease
11. Apollo Hospitals Short-listed to Provide Diagnostics in the UK

Post Your Comments:
(Date:11/21/2009)...ilvia Lopez, by her attorney MICHAEL STEWART FRANK...eme Court, New York County, bearing Index # 112888...underwent a routine transesophageal echocardiogram... an HIV infected scope exposing her to HIV. ,...eing discharged from the procedure and arriving ba...
(Date:11/21/2009)...parel company launches men,s lab coats at Medica 2...ente, Calif. (PRWEB) November 21, 2009 -- Medelita...y announced the launch of its men,s lab coats, whi...ational trade fair for the medical industry held i...n,s collection with three varying lab coat styles,...
(Date:11/20/2009)...erstanding Brain Wiring and Diseases ,, WASHING... Schmahmann, Professor of Neurology at Harvard Med...eneral Hospital in Boston, on Thursday, November 1...field of study called "Connectivity" at the launch...is an award-winning leader in the field of the cer...
(Date:11/20/2009)...men in Competitive Re-election Battles Could Be in... Washington, DC (Vocus) November 20, ...ection next year in races deemed to be competitive...t voting for House Speaker Nancy Pelosi’s he...rnational/ O’Leary Report poll. (The Poll ...
(Date:11/20/2009)...wire-USNewswire/ -- Samuel Gladding is no Scrooge,...to be "happy" during the holidays. As a licensed p...ounseling and chair of the Department of Counselin...h shows that it is the pressure to be happy that o...he holidays. ,, That,s why he,s challenging the...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2
... tea daily can protect you from developing skin ca...re research// to strengthen the findings. Te...the body against Squamous cell carcinomas and Basa... or even years, the researchers say. Squamou...
...ed today says school playgrounds and athletic faci... childhood obesity//, but many are locked and inac...oor and minority neighborhoods. The study is... 1,556 girls in the sixth grade in six metropolita...
...e Virginia Tech sure had the whole world reaching ...university. //An incident unbelievable, the shooti...hed out with deep sympathy and anguish for the fam...t. It will sure take its time for the loss and gri...
...ement therapy are more likely to be diagnosed with...ng //to a study published in the Lancet* today. ...the biggest study of its kind in the world, show t... one additional death from ovarian cancer. T...
...ns for men no-scalpel vasectomies are highly prefe... //there is no definitive statistics to claim abou...een stressed about the importance of the training....he University of Otago in Christchurch, New Zealan...
... with excitement about a possible cure for HIV/AID... Announcing the discovery of a peptide (chain of ...ney dialysis patients, lead researcher Frank Kirch... more and more.” Accordingly, this compound found ...
Other Medicine News:Health News:School Playgrounds and Athletic Facilities Helps To Fight Childhood Obesity 2Health News:Support for Trauma and Grief 2Health News:HRT Increases Incidence and Deaths from Ovarian Cancer 2Health News:No-scalpel Vasectomies by Skilled Surgeons may Speed Recovery 2Health News:No-scalpel Vasectomies by Skilled Surgeons may Speed Recovery 3Health News:HIV/AIDS- Possible Cure From Within 2
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Markets for Assisted Reproductive Devi...4742/Global-Markets-for-Assisted-Reproductive-Devi...=pr&utm_campaign=prnewswire ,, Global Mar... Countries in Europe and Japan. This report includ...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Blue Shield of California Expands CalPERS NetValue Service Area 52337 1Blue Shield of California Expands CalPERS NetValue Service Area 52337 2Blue Shield of California Expands CalPERS NetValue Service Area 52337 3Free Drug Card Has Saved Washington Residents 242 6 Million 52334 1Free Drug Card Has Saved Washington Residents 242 6 Million 52334 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 1Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 3Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 4Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 5Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 6Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 7Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 8
...ics, Inc.,(Nasdaq: PCYC ) today announced that i...calation study to evaluate the safety and tolerabi...nhibitor of Bruton,s tyrosine kinase, or Btk,as a ...refractory B-cell,non-Hodgkin,s lymphoma (NHL). ...sted in humans, and is Pharmacyclics, fourth produ...
...ncy, Binding Capabilities for Antibody Pipeline An...il 9 InNexus Biotechnology Inc. (Toronto Stock Ex...velopment company commercializing the next generat...gy, Dynamic Cross Linking (DXL(TM)), announced tod... its lead preclinical candidate DXL625 (CD20) for ...
Other Medicine Technology:Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5AACR Data Highlights InNexus Preclinical Antibody Candidate 2
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Straight Tip, Size: 16g Outer Cannula)
PremierEdge™ Clear Cornea Knives - Parallel Sides
Terry-Schanzlin Astigmatome - Vacuum Speculum
Medicine Products: